Authors:
Dorrucci, M
Suligoi, B
Serraino, D
Tirelli, U
Rezza, G
Citation: M. Dorrucci et al., Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy, J ACQ IMM D, 26(4), 2001, pp. 377-380
Authors:
Dorrucci, M
Pezzotti, P
Grisorio, B
Minardi, C
Muro, MS
Vullo, V
Monforte, AD
Citation: M. Dorrucci et al., Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens, AIDS, 15(13), 2001, pp. 1733-1736
Authors:
Suligoi, B
Dorrucci, M
Volpi, A
Andreoni, M
Pezzotti, P
Rezza, G
Citation: B. Suligoi et al., Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individuals with known date of seroconversion, AIDS, 15(1), 2001, pp. 133-135
Authors:
Serraino, D
Boschini, A
Carrieri, P
Pradier, C
Dorrucci, M
Dal Maso, L
Ballarini, P
Pezzotti, P
Smacchia, C
Pesce, A
Ippolito, G
Franceschi, S
Rezza, G
Citation: D. Serraino et al., Cancer risk among men with, or at risk of, HIV infection in southern Europe, AIDS, 14(5), 2000, pp. 553-559
Authors:
Rezza, G
Dorrucci, M
Serraino, D
Andreoni, M
Giuliani, M
Zerboni, R
Sarmati, L
Colangeli, V
Salassa, B
Monini, P
Ensoli, B
Pezzotti, P
Citation: G. Rezza et al., Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion, AIDS, 14(11), 2000, pp. 1647-1653
Authors:
Rezza, G
Andreoni, M
Dorrucci, M
Pezzotti, P
Monini, P
Zerboni, R
Salassa, B
Colangeli, V
Sarmati, L
Nicastri, E
Barbanera, M
Pristera, R
Aiuti, F
Ortona, L
Ensoli, B
Citation: G. Rezza et al., Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases, J NAT CANC, 91(17), 1999, pp. 1468-1474
Authors:
Dorrucci, M
Balducci, M
Pezzotti, P
Sinicco, A
Alberici, F
Rezza, G
Citation: M. Dorrucci et al., Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment, J ACQ IMM D, 22(1), 1999, pp. 65-70
Authors:
Dorrucci, M
Rezza, C
Andreoni, M
Pezzotti, P
Nicastri, E
Ventura, L
Zignani, M
Alliegro, MB
Tarantini, G
Salassa, B
Colangeli, V
Mazzarello, G
Ursitti, MA
Barbanera, M
Pristera, R
Castelli, F
Ortona, L
Citation: M. Dorrucci et al., Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS, EUR J EPID, 15(4), 1999, pp. 317-322
Authors:
Lyles, CM
Dorrucci, M
Vlahov, D
Pezzotti, P
Angarano, G
Sinicco, A
Alberici, F
Alcorn, TM
Vella, S
Rezza, G
Citation: Cm. Lyles et al., Longitudinal human immunodeficiency virus type 1 load in the Italian seroconversion study: Correlates and temporal trends of virus load, J INFEC DIS, 180(4), 1999, pp. 1018-1024